Antibody-mediated versus nontargeted delivery in a human small cell lung carcinoma model

Bioconjugate Chemistry

Volumn 9, Issue 2, 1998, Pages 184-191

  Marecos, Edgardo ^a   Weissleder, Ralph ^a   Bogdanov Jr , Alexei ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING SITES; BIOCOMPATIBILITY; BIOLOGICAL ORGANS; CELL MEMBRANES; CONTROLLED DRUG DELIVERY; CYTOLOGY; DISEASES; FLUORESCENCE; HISTOLOGY; MOLECULAR BIOLOGY; TARGETED DRUG DELIVERY; TUMORS;

CELL FRACTION; CELL-BE; CELL/B.E; CELL/BE; GRAFT- COPOLYMERS; LONG CIRCULATING; LUNG CARCINOMA; SMALL CELLS; TUMOUR CELLS; TUMOUR XENOGRAFTS;

MONOCLONAL ANTIBODIES;

EID: 0032030963     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc970146w     Document Type: Article

References (53)

1. Bogdanov, A., Jr., Weissleder, R., and Brady, T. (1995) Long-circulating blood pool imaging agents. Adv. Drug Delivery Rev. 16, 335-348.
2. Bogdanov, A., Jr., Martin, C., Bogdanova, A. V., Brady, T. J., and Weissleder, R. (1996) An adduct of cis-diamminedichloroplatinum(II) and poly(ethylene glycol)poly(L-lysine)-succinate: synthesis and cytotoxic properties. Bioconjugate Chem. 7, 144-149.
3. Hellstrom, I., Garrigues, H. J., Garrigues, U., and Hellstrom, K. E. (1990) Highly tumor-reactive, internalizing, mouse monoclonal antibodies to Le(y)-related cell surface antigens. Cancer Res. 50, 2183-2190.
4. Garrigues, J., Garrigues, U., Hellstrom, I., and Hellstrom, K. E. (1993) Ley specific antibody with potent anti-tumor activity is internalized and degraded in lysosomes. Am. J. Pathol. 142, 607-622.
5. Buchsbaum, D. J. (1995) Experimental approaches to increase radiolabeled antibody localization in tumors. Cancer Res. 55, 5729s-5732s.
6. von Mehren, M., and Weiner, L. M. (1996) Monoclonal antibody-based therapy. Curr. Opin. Oncol. 8, 493-498.
7. Adams, G. P., McCartney, J. E., Tai, M. S., Oppermann, H., Huston, J. S., Stafford, W. F. d., Bookman, M. A., Fand, I., Houston, L. L., and Weiner, L. M. (1993) Highly specific in vivo tumor targeting by monovalent and divalent forms of 741F8 anti-c-erbB-2 single-chain Fv. Cancer Res. 53, 4026-4034.
8. George, A. J., Jamar, F., Tai, M. S., Heelan, B. T., Adams, G. P., McCartney, J. E., Houston, L. L., Weiner, L. M., Oppermann, H., Peters, A. M., et al. (1995) Radiometal labeling of recombinant proteins by a genetically engineered minimal chelation site: technetium-99m coordination by single-chain Fv antibody fusion proteins through a C-terminal cysteinyl peptide. Proc. Natl. Acad. Sci. U.S.A. 92, 8358-8362.
9. Dean, C. J., Eccles, S. A., Valeri, M., Box, G., Allan, S., McFarlane, C., Sandle, J., and Styles, J. (1993) Rat MAbs to the product of the c-erbB-2 proto-oncogene for diagnosis and therapy in breast cancer. Cell Biophys. 22, 111-127.
10. Biersack, H. J., Briele, B., Hotze, A. L., Oehr, P., Qian, L., Mekkawy, M. A., and Shih, W. J. (1992) The role of nuclear medicine in oncology. Ann. Nucl. Med. 6, 131-136.
11. Abdel-Nabi, H. H., and Doerr, R. J. (1992) Multicenter clinical trials of monoclonal antibody B72.3-GYK-DTPA 111In (111In-CYT-103; OncoScint CR103) in patients with colorectal carcinoma. Targeted Diagn. Ther. 6, 73-88.
12. Leitha, T., Walter, R., Schlick, W., and Dudczak, R. (1991) 99mTc-anti-CEA radioimmunoscintigraphy of lung adenocarcinoma. Chest 99, 14-19.
13. Saleh, M. N., Wheeler, R. H., Lee, J. Y., Khazaeli, M. B., Unger, M. W., Russell, C. H., and LoBuglio, A. F. (1991) In-111 labeled monoclonal anti-carcinoembryonic antigen antibody (ZCE025) in the immunoscintigraphic imaging of metastatic antigen-producing adenocarcinomas. Clin. Nucl. Med. 16, 110-116.
14. 123I-labeled monoclonal antibody HMFG-2 compared to surgical findings. In Monoclonal Antibodies for Cancer Detection and Therapy, p 10, Academic Press, New York.
15. Surwit, E. A., Childers, J. M., Krag, D. N., Katterhagen, J. G., Gallion, H. H., Waggoner, S., and Mann, W. J., Jr. (1993) Clinical assessment of 111In-CYT-103 immunoscintigraphy in ovarian cancer. Gynecol. Oncol. 48, 285-292.
16. Holm, J., Hansen, S. I., Hoier-Madsen, M., Sondergaard, K., and Bzorek, M. (1994) Folate receptor of human mammary adenocarcinoma. APMIS 102, 413-419.
17. Franklin, W. A., Waintrub, M., Edwards, D., Christensen, K., Prendegrast, P., Woods, J., Bunn, P. A., and Kolhouse, J. F. (1994) New anti-lung-cancer antibody cluster 12 reacts with human folate receptors present on adenocarcinoma. Int. J. Cancer Suppl. 8, 89-95.
18. Coney, L. R., Mezzanzanica, D., Sanborn, D., Casalini, P., Colnaghi, M. I., and Zurawski, V. R., Jr. (1994) Chimeric murine-human antibodies directed against folate binding receptor are efficient mediators of ovarian carcinoma cell killing. Cancer Res. 54, 2448-2455.
19. Epstein, A. L., Khawli, L. A., Chen, F.-M., Hu, P., Glasky, M. S., and Taylor, C. R. (1995) Tumor necrosis imaging and treatment of solid tumors. In Targeted Delivery of Imaging Agents, pp 259-288, CRC Press, Boca Raton, FL.
20. Epstein, A. L., Chen, F.-M., and Taylor, C. R. (1988) A novel method for the detection of necrotic lesions in human cancers. Cancer Res. 48, 5842.
21. 123I-labelled N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin conjugate containing galactosamine following intravenous administration to nude mice bearing hepatic human colon carcinoma. J. Drug Targeting 3, 385-390.
22. Pimm, M. V., Perkins, A. C., Strohalm, J., Ulbrich, K., and Duncan, R. (1996) Gamma scintigraphy of the biodistribution of 123I-labelled N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin conjugates in mice with transplanted melanoma and mammary carcinoma. J. Drug Targeting 3, 375-383.
23. Jain, R. (1988) Determinants of tumor blood flow: A review. Cancer Res. 48, 2641-2658.
24. Trotter, M., Chaplin, D., Durand, R., and Olive, P. (1989) The use of fluorescent probes to identify regions of transient perfusion in murine tumors. Int. J. Radiat. Oncol., Biol., Phys. 16, 931-934.
25. Maeda, H., and Matsumura, Y. (1989) Tumoritropic and lymphotropic principles of macromolecular drugs. Crit. Rev. Ther. Drug Carrier Syst. 6, 193-210.
26. Bogdanov, A., Jr., Wright, S. C., Marecos, E. M., Bogdanova, A. V., Martin, C., Petherick, P., and Weissleder, R. (1997) A long-circulating co-polymer in "passive targeting" to solid tumors. J. Drug Targeting 4, 321-330.
27. Yuan, F., Leunig, M., Huang, S. K., Berk, D. A., Papahadjopoulos, D., and Jain, R. K. (1994) Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft. Cancer Res. 54, 3352-3356.
28. Yuan, F., Dellian, M., Fukumura, D., Leunig, M., Berk, D. A., Torchilin, V. P., and Jain, R. K. (1995) Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. Cancer Res. 55, 3752-3756.
29. Oku, N., Namba, Y., and Okada, S. (1992) Tumor accumulation of novel RES-avoiding liposomes. Biochim. Biophys. Acta 1126, 255-260.
30. Litzinger, D. C., Buiting, A. M., van Rooijen, N., and Huang, L. (1994) Effect of liposome size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomes. Biochim. Biophs. Acta 1190, 99-107.
31. Zou, Y., Ling, Y. H., Reddy, S., Priebe, W., and Perez-Soler, R. (1995) Effect of vesicle size and lipid composition on the in vivo tumor selectivity and toxicity of the non-cross-resistant anthracycline annamycin incorporated in liposomes. Int. J. Cancer 61, 666-671.
32. Francis, G. E., Delgado, C., Fisher, D., Malik, F., and Agrawal, A. K. (1996) Polyethylene glycol modification: relevance of improved methodology to tumour targeting. J. Drug Targeting 3, 321-340.
33. Pratten, M. K., Duncan, R., Cable, H. C., Schnee, R., Ringsdorf, H., and Lloyd, J. B. (1981) Pinocytic uptake of divinyl ether-maleic anhydride (pyran copolymer) and its failure to stimulate pinocytosis. Chem. Biol. Interact. 35, 319-330.
34. 125I-labelled poly(vinylpyrrolidone) on its pinocytosis by rat visceral yolk sacs and rat peritoneal macrophages. Biochem. J. 196, 49-55.
35. Quintart, J., Leroy-Houyet, M. A., Trouet, A., and Baudhuin, P. (1979) Endocytosis and chloroquine accumulation during the cell cycle of hepatoma cells in culture. J. Cell Biol. 82, 644-653.
36. Illinger, D., Italiano, L., Beck, J., Waltzinger, C., and Kuhry, J. (1993) Comparative evolution of endocytosis levels and of the cell surface area during the L929 cell cycle: a fluorescence study with TMA.-DPH. Biol. Cell. 79, 265-268.
37. Bogdanov, A. A., Jr., Weissleder, R., Frank, H. W., Bogdanova, A. V., Nossif, N., Schaffer, B. K., Tsai, E., Papisov, M. I., and Brady, T. J. (1993) A new macromolecule as a contrast agent for MR angiography: preparation, properties, and animal studies. Radiology 187, 701-706.
38. Schreiber, G. J., Hellstrom, K. E., and Hellstrom, I. (1992) An unmodified anticarcinoma antibody, BR96, localizes to and inhibits the outgrowth of human tumors in nude mice. Cancer Res. 52, 3262-3266.
39. Schulze, E., Ferrucci, J., Poss, K., Lapointe, L., Bogdanova, A., and Weissleder, R. (1995) Cellular uptake and trafficking of a prototypical magnetic iron oxide label in vitro. Invest. Radiol. 30, 604-610.
40. Lin, K., Nagy, J. A., Xu, H., Shockley, T. R., Yarmush, M. L., and Dvorak, H. F. (1994) Compartmental distribution of tumor-specific monoclonal antibodies in human melanoma xenografts. Cancer Res. 54, 2269-2277.
41. Schnitzer, J. E., Allard, J., and Oh, P. (1995) NEM inhibits transcytosis, endocytosis, and capillary permeability: implication of caveolae fusion in endothelia. Am. J. Physiol. 268, H48-H55.
42. Trail, P., Willner, D., Lasch, S., Henderson, A., Hofstead, S., Casazza, A., Firestone, R., Hellström, I., and Hellström, K. (1993) Cure of xenografted human carcinomas by BR96-doxorubicin immunoconjugates. Science 261, 212-215.
43. Bogdanov, A., Jr., Callahan, R., Wilkinson, R., Martin, C., Cameron, J., Fishman, A., Brady, T., and Weissleder, R. (1994) A synthetic copolymer kit for radionuclide blood pool imaging. J. Nucl. Med. 35, 1880-1886.
44. Gupta, H., Weissleder, R., Bogdanov, A. A., Jr., and Brady, T. J. (1995) Experimental gastrointestinal hemorrhage: detection with contrast-enhanced MR imaging and scintigraphy. Radiology 196, 239-244.
45. Gupta, H., Wilkinson, R. A., Bogdanov, A. A., Jr., Callahan, R. J., and Weissleder, R. (1995) Inflammation: imaging with methoxy polytethylene glycol)-poly-L-lysine-DTPA, a long-circulating graft copolymer. Radiology 197, 665-669.
46. Shockley, T. R., Lin, K., Nagy, J. A., Tompkins, R. G., Yarmush, M. L., and Dvorak, H. F. (1992) Spatial distribution of tumor-specific monoclonal antibodies in human melanoma xenografts. Cancer Res. 52, 367-376.
47. Baxter, L. T., and Jain, R. K. (1991) Transport of fluid and macromolecules in tumors. IV. A microscopic model of the perivascular distribution. Microvasc. Res. 41, 252-272.
48. Baxter, L. T., and Jain, R. K. (1991) Transport of fluid and macromolecules in tumors. III. Role of binding and metabolism. Microvasc. Res. 41, 5-23.
49. Jain, R. K. (1990) Physiological barriers to delivery of monoclonal antibodies and other macromolecules in tumors. Cancer Res. 50, 814-819.
50. Duncan, R., Starling, D., Rypacek, F., Drobnik, J., and Lloyd, J. B. (1982) Pinocytosis of poly(α,β-(N-2-hydroxyethyl))DL-aspartamide and a tyramine derivative by rat visceral yolk sacs cultured in vitro. Ability of phenolic residues to enhance the rate of pinocytic capture of a macromolecule. Biochim. Biophys. Acta 717, 248-254.
51. Duncan, R., Kopeckova-Rejmanova, P., Strohalm, J., Hume, I., Cable, H. C., Pohl, J., Lloyd, J. B., and Kopecek, J. (1987) Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. I. Evaluation of daunomycin and puromycin conjugates in vitro. Br. J. Cancer 55, 165-174.
52. Pratten, M., and Lloyd, J. (1986) Pinocytosis and phagocytosis: the effect of size of a particulate substrate on its mode of capture by rat peritoneal macrophages cultured in vitro. Biochim. Biophys. Acta 881, 307-313.
53. Racoosin, E. L., and Swanson, J. A. (1993) Macropinosome maturation and fusion with tubular lysosomes in macrophages. J. Cell Biol. 121, 1011-1020.